Venous Stents Market to Grow at a CAGR of 9.7% to reach US$ 1,727.4 Mn from 2017 to 2025
[Research Report] The Venous stents in healthcare market was valued at US$ 829.0 million in 2017 and it is projected to reach US$ 1,727.4 million by 2025; it is expected to grow at a CAGR of 9.7% from 2018 to 2025.
The venous stents are mesh tubes made up metal that expands against the blocked veins or the narrowed veins. These stents play role of a scaffold that assist in keeping the walls of veins open. The venous stents are generally placed in the central veins which are found in legs, chest and abdomen. The venous stents are used to treat conditions such as chronic deep vein thrombosis (DVT), post thrombotic syndrome and more. The growth of the Venous stents in healthcare market is attributed to the rising venous diseases, technological advancements in stent technology and rising geriatric populations are key drivers for the growth of the market. However, the growth of the market is restrained by various factors such as stringent regulations for approval and high cost of surgical procedures.
The Venous stents in healthcare market is expected to witness substantial growth post-pandemic. The Venous stents in healthcare market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Venous Stents Market: Strategic Insights
Market Size Value in US$ 829.0 Million in 2017 Market Size Value by US$ 1,727.4 Million by 2025 Growth rate CAGR of 9.7% from 2018-2025 Forecast Period 2018-2025 Base Year 2018
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Venous Stents Market: Strategic Insights
| Market Size Value in | US$ 829.0 Million in 2017 |
| Market Size Value by | US$ 1,727.4 Million by 2025 |
| Growth rate | CAGR of 9.7% from 2018-2025 |
| Forecast Period | 2018-2025 |
| Base Year | 2018 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Growing Applications of Venous stents in Healthcare to Drive Venous stents in Healthcare Market Growth
Conditions that damage the veins are termed as venous diseases. Common venous disorders include: venous thrombosis, deep vein thrombosis, venous stasis, venous ulcers, arteriovenous fistula, post-thrombotic syndrome, thrombophlebitis and others. According to the Johns Hopkins University around 15% of the US population suffers from varicose veins. Also, according to the Centers for Disease Control and Prevention, every year approximately 900,000 (1 - 2 per 1,000) people are affected by deep vein thrombosis (DVT) in the United States. It also mentioned that 33% of people with DVT will have recurrence of DVT within 10 years. Furthermore, thrombophilia is the condition wherein predisposition leads to formation of clots. The predisposition to form clots can arise from genetic factors, genetic thrombophilia results when there is deficiency in inherited factor, such as antithrombin or protein C. The Centers for Disease Control and Prevention estimated that 5-8% people in the US have inherited thrombophilias.
Owing to the rising cases of venous diseases in the regions and in various countries, the need and demand for the venous stents for the treatment of the venous disorders increases, thus enhancing the market growth in the future years.
Advancement in the field of stent technology has equally enhanced the market for venous stents. Many industry players have come up with innovative types of venous stents in last few years. The defects and technical shortcomings for performing venous stenting procedures have led to a revolution of the newer nitinol stents. For instance, in January 2018, Medtronic plc. broadcasted an initiation of its investigational device exemption (IDE) study for the Abre, its venous self-expanding stent system. The new abre stent is developed for permanent implant in the iliofemoral vein. Upon placement of the Abre stent, the stent offers optimized balance of strength and flexibility to exert an outward force and open the vein. Similarly, in November 2016, Cook Medical announced the initiation of VIVO clinical study that assesses the safety and effectiveness of the Zilver Vena venous stent that is used for the treatment of symptomatic iliofemoral venous outflow obstruction. Thus, many companies are growing their venous product portfolio to offer a comprehensive portfolio for the treatment of venous diseases.
Advancement in venous stents has made the treatment of venous diseases easy and accurate. These technological advancements are likely to grow the market in near future.
Incidence rates for deep venous thrombosis (DVT) and pulmonary embolism (PE) increases with increasing age in both men and women. This is due to age related alterations in thrombotic factors and laxity in large venous valves. According to the NHS foundation, 90-95% of deep venous thrombosis or pulmonary embolism cases are in people aged over 40 years. Furthermore, chronic diseases like cancer, surgeries or immobilization, transvenous pacemaker, central venous catheters, infection, kidney disease, thrombophilia, and leg paresis from neurological disease are more prevalent in aged population and all these diseases are independent predictors of venous thromboembolism events.
Globally the geriatric population is increasing, every country is experiencing the rise in older population. According to the United Nations data from World Population Prospects 2017, 962 million people are aged 60 or over in the world and is expected to reach 2.1 billion by 2050 and 3.1 billion by 2100. It also mentioned that Europe is having the largest share of old aged population about 25%. Thus, the growing geriatric population, increases the applications of venous stents and eventually favors market growth.
Technology-Based Insights
In terms of technology, the Venous stents in healthcare market is segmented into wallstent technology and iliac vein stent technology. In 2017, the iliac vein stent technology segment held a largest market share of 73.9% of the venous stents, by technology.
Application-Based Insights
Based on application, the Venous stents in healthcare market is segmented into legs, chest, and abdomen. The leg segment is anticipated to grow at a CAGR of 9.6% during the forecast period. The growth of leg segment is primarily driven due to increasing number of the incidences for the deep vein thrombosis in the geriatric population.
Disease-Based Insights
In terms of disease, the Venous stents in healthcare market is segmented into post thrombotic syndrome, chronic deep vein thrombosis, may-thurner syndrome, hemodialysis/arteriovenous fistulae and others. In 2017, the chronic deep vein thrombosis segment held a largest market share of 30.4% of the venous stents, by disease.
The Venous stents in healthcare market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.
Venous Stents Market Report Scope
Venous stents in Healthcare Market – by Technology
- Wallstent Technology,
- Iliac Vein Stent Technology
Venous stents in Healthcare Market – by Application
- Legs
- Chest
- Abdomen
Venous stents in Healthcare Market – by Disease
- Post Thrombotic Syndrome,
- Chronic Deep Vein Thrombosis,
- May-Thurner Syndrome,
- Hemodialysis/Arteriovenous Fistulae, and
- Others
Venous stents in Healthcare Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South America and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Boston Scientific Corporation
- C. R Bard (acquired by BD)
- Jotech GMBH (acquired by Cryolife, Inc.)
- Cook
- W.L Gore & Associates
- Optimed Medizinische Instrumente GMBH
- Medtronic
- Medica Germany GMBH & Co. KG
- Cordis
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology ; Application ; Disease ; and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
TABLE OF CONTENTS
1. INTRODUCTION 19
1.1 SCOPE OF THE STUDY 19
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 19
2. GLOBAL VENOUS STENTS MARKET – KEY TAKEAWAYS 20
3. GLOBAL VENOUS STENTS MARKET – MARKET LANDSCAPE 23
3.1 OVERVIEW 23
3.2 MARKET SEGMENTATION 23
3.2.1 Global Venous stents Market – By Product 24
3.2.2 Global Venous stents Market – By Application 24
3.2.3 Global Venous stents Market – By Disease 25
3.2.4 Global Venous stents Market – By Geography 25
4. GLOBAL VENOUS STENTS MARKET – KEY MARKET DYNAMICS 26
4.1 KEY MARKET DRIVERS 26
4.1.1 Rising Prevalence of Venous Diseases 26
4.1.2 Technological Advancements in Stent Technology 26
4.1.3 Rising Global Geriatric Population 27
4.2 KEY MARKET RESTRAINTS 27
4.2.1 Stringent Regulations For Approval 27
4.2.2 High Cost Of Surgical Procedures 27
4.3 KEY MARKET OPPORTUNITIES 28
4.3.1 Emerging Markets 28
4.4 FUTURE TRENDS 28
4.4.1 Development of Advanced Venous Stents 28
4.5 IMPACT ANALYSIS 29
5. VENOUS STENTS MARKET – GLOBAL ANALYSIS 30
5.1 GLOBAL VENOUS STENTS REVENUE FORECASTS AND ANALYSIS 30
5.2 GLOBAL VENOUS STENTS, BY GEOGRAPHY - FORECASTS AND ANALYSIS 31
5.3 PERFORMANCE OF KEY PLAYERS 32
5.3.1 Boston Scientific Corporation 32
5.3.2 C. R. Bard, Inc. 32
5.4 EXPERT OPINIONS 33
6. GLOBAL VENOUS STENTS MARKET ANALYSIS– BY TECHNOLOGY 34
6.1 OVERVIEW 34
6.2 WALLSTENT TECHNOLOGY 35
6.2.1 Overview 35
6.2.2 Global Wallstent Technology Market Revenue and Forecasts to 2025 (US$ Mn) 35
6.3 ILIAC VEIN STENT TECHNOLOGY 36
6.3.1 Overview 36
6.3.2 Global Iliac Vein Stent Technology Market Revenue and Forecasts to 2025 (US$ Mn) 36
7. GLOBAL VENOUS STENTS MARKET ANALYSIS– BY APPLICATION 37
7.1 OVERVIEW 37
7.2 LEGS MARKET 38
7.2.1 Overview 38
7.2.2 Global Legs Market Revenue and Forecasts to 2025 (US$ Mn) 38
7.3 CHEST MARKET 39
7.3.1 Overview 39
7.3.2 Global Chest Market Revenue and Forecasts to 2025 (US$ Mn) 39
7.4 ABDOMEN MARKET 40
7.4.1 Overview 40
7.4.2 Global Abdomen Market Revenue and Forecasts to 2025 (US$ Mn) 40
8. GLOBAL VENOUS STENTS MARKET ANALYSIS– BY DISEASES 41
8.1 OVERVIEW 41
8.2 POST THROMBOTIC SYNDROME MARKET 42
8.2.1 Overview 42
8.2.2 Global Post Thrombotic Syndrome Market Revenue and Forecasts to 2025 (US$ Mn) 42
8.3 CHRONIC DEEP VEIN THROMBOSIS 43
8.3.1 Overview 43
8.3.2 Global Chronic Deep Vein Thrombosis Market Revenue and Forecasts to 2025 (US$ Mn) 43
8.4 MAY-THURNER SYNDROME 44
8.4.1 Overview 44
8.4.2 Global May-Thurner Syndrome Market Revenue and Forecasts to 2025 (US$ Mn) 44
8.5 HEMODIALYSIS/ARTERIOVENOUS FISTULAE 45
8.5.1 Overview 45
8.5.2 Global Hemodialysis/Arteriovenous Fistulae Market Revenue and Forecasts to 2025 (US$ Mn) 45
8.6 OTHERS 46
8.6.1 Overview 46
8.6.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn) 46
9. NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 47
9.1 OVERVIEW 47
9.2 NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 48
9.3 NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 48
9.4 NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 49
9.5 NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 49
9.6 NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 50
9.7 US VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
9.7.1 US Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 51
9.7.2 US Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 51
9.7.3 US Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 52
9.7.4 US Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 52
9.8 CANADA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53
9.8.1 Canada Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 53
9.8.2 Canada Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 54
9.8.3 Canada Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 54
9.8.4 Canada Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 54
9.9 MEXICO VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
9.9.1 Mexico Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 55
9.9.2 Mexico Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 56
9.9.3 Mexico Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 56
9.9.4 Mexico Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 56
10. EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 57
10.1 OVERVIEW 57
10.2 EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
10.3 EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 58
10.4 EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 59
10.5 EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 59
10.6 EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 60
10.7 GERMANY VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
10.7.1 Germany Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 61
10.7.2 Germany Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 62
10.7.3 Germany Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 62
10.7.4 Germany Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 62
10.8 UK VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63
10.8.1 UK Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 63
10.8.2 UK Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 64
10.8.3 UK Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 64
10.8.4 UK Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 64
10.9 FRANCE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 65
10.9.1 France Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 65
10.9.2 France Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 66
10.9.3 France Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 66
10.9.4 France Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 66
11. ASIA-PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 67
11.1 OVERVIEW 67
11.2 ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68
11.3 ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 68
11.4 ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 69
11.5 ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 69
11.6 ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 70
11.7 CHINA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
11.7.1 China Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 71
11.7.2 China Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 71
11.7.3 China Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 72
11.7.4 China Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 72
11.8 JAPAN VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
11.8.1 Japan Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 73
11.8.2 Japan Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 74
11.8.3 Japan Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 74
11.8.4 Japan Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 74
11.9 INDIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75
11.9.1 India Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 75
11.9.2 India Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 76
11.9.3 India Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 76
11.9.4 India Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 76
12. MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 77
12.1 OVERVIEW 77
12.2 MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
12.3 MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 78
12.4 MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 79
12.5 MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 79
12.6 MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 80
12.7 U.A.E. VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
12.7.1 U.A.E. Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 81
12.7.2 U.A.E. Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 82
12.7.3 U.A.E. Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 82
12.7.4 U.A.E. Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 82
12.8 SAUDI ARABIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 83
12.8.1 Saudi Arabia Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 83
12.8.2 Saudi Arabia Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 84
12.8.3 Saudi Arabia Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 84
12.8.4 Saudi Arabia Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 84
12.9 SOUTH AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 85
12.9.1 South Africa Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 85
12.9.2 South Africa Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 86
12.9.3 South Africa Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 86
12.9.4 South Africa Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 86
13. SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 87
13.1 OVERVIEW 87
13.2 SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 88
13.3 SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 88
13.4 SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 89
13.5 SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 89
13.6 SOUTH & CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 90
13.7 BRAZIL VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 91
13.7.1 Brazil Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 91
13.7.2 Brazil Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 92
13.7.3 Brazil Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 92
13.7.4 Brazil Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 92
14. VENOUS STENTS MARKET –KEY COMPANY PROFILES 93
14.1 JOTEC GMBH (ACQUIRED BY CRYOLIFE, INC.) 93
14.1.1 Key Facts 93
14.1.2 Business Description 93
14.1.3 Financial Information 94
14.1.4 Product Portfolio 94
14.1.5 Key Developments 94
14.2 W. L. GORE & ASSOCIATES. 95
14.2.1 Key Facts 95
14.2.2 Business Description 95
14.2.3 Financial Overview 95
14.2.4 Product Portfolio 95
14.2.5 Key Developments 95
14.3 OPTIMED MEDIZINISCHE INSTRUMENTE GMBH 96
14.3.1 Key Facts 96
14.3.2 Business Description 96
14.3.3 Financial Overview 96
14.3.4 Product Portfolio 96
14.3.5 Key Developments 96
14.4 BOSTON SCIENTIFIC CORPORATION 97
14.4.1 Key Facts 97
14.4.2 Business Description 97
14.4.3 Financial Overview 98
14.4.4 Product Portfolio 98
14.4.5 Key Developments 98
14.5 C. R. BARD, INC. (ACQUIRED BY BD) 99
14.5.1 Key Facts 99
14.5.2 Business Description 99
14.5.3 Financial Information 100
14.5.4 Product Portfolio 100
14.5.5 Key Developments 100
14.6 COOK 101
14.6.1 Key Facts 101
14.6.2 Business Description 101
14.6.3 Financial Overview 101
14.6.4 Product Portfolio 101
14.6.5 Key Developments 102
14.7 MEDTRONIC 103
14.7.1 Key Facts 103
14.7.2 Business Description 103
14.7.3 Financial Overview 104
14.7.4 Product Portfolio 104
14.7.5 Key Developments 104
14.8 MEDICA GERMANY GMBH & CO. KG 105
14.8.1 Key Facts 105
14.8.2 Business Description 105
14.8.3 Financial Overview 105
14.8.4 Product Portfolio 105
14.8.5 Key Developments 105
14.9 CORDIS (ACQUIRED BY CARDINAL HEALTH) 106
14.9.1 Key Facts 106
14.9.2 Business Description 106
14.9.3 Financial Overview 107
14.9.4 Product Portfolio 107
14.9.5 Key Developments 107
15. APPENDIX 108
15.1 ABOUT THE INSIGHT PARTNERS 108
15.2 GLOSSARY OF TERMS 109
15.3 METHODOLOGY 112
15.3.1 Coverage 113
15.3.2 Secondary Research 114
15.3.3 Primary Research 114
LIST OF TABLES
TABLE 1. NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 48
TABLE 2. NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 49
TABLE 3. NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 49
TABLE 4. US VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 51
TABLE 5. US VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 52
TABLE 6. US VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 52
TABLE 7. CANADA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 54
TABLE 8. CANADA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 54
TABLE 9. CANADA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 54
TABLE 10. MEXICO VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 56
TABLE 11. MEXICO VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 56
TABLE 12. MEXICO VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 56
TABLE 13. EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 58
TABLE 14. EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 59
TABLE 15. EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 59
TABLE 16. GERMANY VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 62
TABLE 17. GERMANY VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 62
TABLE 18. GERMANY VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 62
TABLE 19. UK VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 64
TABLE 20. UK VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 64
TABLE 21. UK VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 64
TABLE 22. FRANCE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 66
TABLE 23. FRANCE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 66
TABLE 24. FRANCE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 66
TABLE 25. ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 68
TABLE 26. ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 69
TABLE 27. ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 69
TABLE 28. CHINA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 71
TABLE 29. CHINA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 72
TABLE 30. CHINA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 72
TABLE 31. JAPAN VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 74
TABLE 32. JAPAN VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 74
TABLE 33. JAPAN VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 74
TABLE 34. INDIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 76
TABLE 35. INDIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 76
TABLE 36. INDIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 76
TABLE 37. MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 78
TABLE 38. MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 79
TABLE 39. MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 79
TABLE 40. U.A.E. VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 82
TABLE 41. U.A.E. VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 82
TABLE 42. U.A.E. VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 82
TABLE 43. SAUDI ARABIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 84
TABLE 44. SAUDI ARABIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 84
TABLE 45. SAUDI ARABIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 84
TABLE 46. SOUTH AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 86
TABLE 47. SOUTH AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 86
TABLE 48. SOUTH AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 86
TABLE 49. SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 88
TABLE 50. SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 89
TABLE 51. SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 89
TABLE 52. BRAZIL VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 92
TABLE 53. BRAZIL VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 92
TABLE 54. BRAZIL VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 92
TABLE 55. GLOSSARY OF TERMS, VENOUS STENTS 109
LIST OF FIGURES
FIGURE 1. ASIA PACIFIC VENOUS STENTS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2017 & 2025 20
FIGURE 2. GLOBAL VENOUS STENTS MARKET BY TECHNOLOGY, MARKET SHARE (%), 2017 21
FIGURE 3. GLOBAL VENOUS STENTS MARKET BY APPLICATION, MARKET SHARE (%), 2017 21
FIGURE 4. GLOBAL VENOUS STENTS MARKET BY DISEASE, MARKET SHARE (%), 2017 22
FIGURE 5. VENOUS STENTS MARKET SEGMENTATION 23
FIGURE 6. VENOUS STENTS MARKET SEGMENTATION, BY REGION 24
FIGURE 7. VENOUS STENTS MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 29
FIGURE 8. GLOBAL VENOUS STENTS – REVENUE FORECASTS AND ANALYSIS – 2016- 2025 30
FIGURE 9. GLOBAL VENOUS STENTS – BY GEOGRAPHY FORECASTS AND ANALYSIS – 2017- 2025 31
FIGURE 10. GLOBAL VENOUS STENTS MARKET, BY TECHNOLOGY 2017 & 2025 (%) 34
FIGURE 11. GLOBAL WALLSTENT TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 35
FIGURE 12. GLOBAL ILIAC VEIN STENT TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 36
FIGURE 13. GLOBAL VENOUS STENTS MARKET, BY APPLICATION 2017 & 2025 (%) 37
FIGURE 14. GLOBAL LEGS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 38
FIGURE 15. GLOBAL CHEST MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 39
FIGURE 16. GLOBAL ABDOMEN MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 40
FIGURE 17. GLOBAL VENOUS STENTS MARKET, BY DISEASE 2017 & 2025 (%) 41
FIGURE 18. GLOBAL POST THROMBOTIC SYNDROME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 42
FIGURE 19. GLOBAL CHRONIC DEEP VEIN THROMBOSIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 43
FIGURE 20. GLOBAL MAY-THURNER SYNDROME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 44
FIGURE 21. GLOBAL HEMODIALYSIS/ARTERIOVENOUS FISTULAE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 45
FIGURE 22. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 46
FIGURE 23. NORTH AMERICA VENOUS STENTS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 47
FIGURE 24. NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 48
FIGURE 25. NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 50
FIGURE 26. US VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
FIGURE 27. CANADA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53
FIGURE 28. MEXICO VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
FIGURE 29. EUROPE VENOUS STENTS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 57
FIGURE 30. EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
FIGURE 31. EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 60
FIGURE 32. GERMANY VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
FIGURE 33. UK VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63
FIGURE 34. FRANCE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 65
FIGURE 35. ASIA PACIFIC VENOUS STENTS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 67
FIGURE 36. ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68
FIGURE 37. ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 70
FIGURE 38. CHINA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 71
FIGURE 39. JAPAN VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
FIGURE 40. INDIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75
FIGURE 41. MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 77
FIGURE 42. MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
FIGURE 43. MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 80
FIGURE 44. U.A.E. VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
FIGURE 45. SAUDI ARABIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
FIGURE 46. SOUTH AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 85
FIGURE 47. SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 87
FIGURE 48. SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 88
FIGURE 49. SOUTH & CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 90
FIGURE 50. BRAZIL VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 91
The List of Companies
- Boston Scientific Corporation
- C. R Bard (acquired by BD)
- Jotech GMBH (acquired by Cryolife, Inc.)
- Cook
- W.L Gore & Associates
- Optimed Medizinische Instrumente GMBH
- Medtronic
- Medica Germany GMBH & Co. KG
- Cordis (acquired by Cardinal Health)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For